Prevalence of and Risk Factors for Anal Human Papillomavirus Infection Among Young Healthy Women in Costa Rica

Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial

(2011) Aimée R Kreimer et al.   LANCET ONCOLOGY

Human papillomavirus genotype distribution in anal cancer in France: The EDiTH V study

(2010) Laurent Abramowitz et al.   INTERNATIONAL JOURNAL OF CANCER

Prevalence of and Risk Factors for Anal Human Papillomavirus Infection in Men Who Have Sex with Women: A Cross‐National Study

(2010) Alan G. Nyitray et al.   JOURNAL OF INFECTIOUS DISEASES

Cancers attributable to human papillomavirus infection

(2010) Andrew E. Grulich et al.   Sexual Health

An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England

(2009) D Robinson et al.   BRITISH JOURNAL OF CANCER

Duration and Clearance of Anal Human Papillomavirus (HPV) Infection among Women: The Hawaii HPV Cohort Study

(2009) Yurii B. Shvetsov et al.   CLINICAL INFECTIOUS DISEASES

Anal human papillomavirus infection and abnormal anal cytology in women with genital neoplasia

(2009) Ina U. Park et al.   GYNECOLOGIC ONCOLOGY

Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions

(2008) Brooke E. Hoots et al.   INTERNATIONAL JOURNAL OF CANCER

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis

(2008) Hugo De Vuyst et al.   INTERNATIONAL JOURNAL OF CANCER

Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica

(2008) Rolando Herrero et al.   VACCINE